ArticleJournal of bacteriology1990
Characterization of ompF domains involved in Escherichia coli K-12 sensitivity to colicins A and N.
Article in Journal of bacteriology, 1990. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 42 citations in OpenAlex.
- Bacterial pore-forming toxins.Microbiology (Reading, England) · 2022Article
- The antibacterial toxin colicin N binds to the inner core of lipopolysaccharide and close to its translocator protein.Molecular microbiology · 2014Article
- The unstructured domain of colicin N kills Escherichia coli.Molecular microbiology · 2013Article
- Colicin N binds to the periphery of its receptor and translocator, outer membrane protein F.Structure (London, England : 1993) · 2008Article
- Colicin biology.Microbiology and molecular biology reviews : MMBR · 2007Review
- Release of immunity protein requires functional endonuclease colicin import machinery.Journal of bacteriology · 2006Article
- Colicin occlusion of OmpF and TolC channels: outer membrane translocons for colicin import.Biophysical journal · 2004Article
- Colicins, spermine and cephalosporins: a competitive interaction with the OmpF eyelet.The Biochemical journal · 2003Article
- Dynamic aspects of colicin N translocation through the Escherichia coli outer membrane.Journal of bacteriology · 1996Article
- Structural and functional alterations of a colicin-resistant mutant of OmpF porin from Escherichia coli.Proceedings of the National Academy of Sciences of the United States of America · 1994Article
- Specific regions of Escherichia coli OmpF protein involved in antigenic and colicin receptor sites and in stable trimerization.Journal of bacteriology · 1993Article
- Colicin A unfolds during its translocation in Escherichia coli cells and spans the whole cell envelope when its pore has formed.The EMBO journal · 1992Article
- Internal deletions in the FhuA receptor of Escherichia coli K-12 define domains of ligand interactions.Journal of bacteriology · 1991Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Various ompF-ompC, ompC-ompF, and ompF-ompC-ompF chimeric genes were used to locate the domains of the OmpF protein involved in cellular sensitivity to colicins. Various parts of the porin participate in the entry of colicins. Colicin N receptor activity was found to require three regions: RN1, located between residues 1 and 63; RN2, located between residues 115 and 262; and RN3, located between residues 279 and 297. The central domain from residues 143 to 262 is involved during the translocation step after the binding step. A large region, including residues 1 to 262, is necessary during colicin A entry. The locations and interactions between these domains specifically required for the uptake of colicins to occur are described and discussed with regard to the homology and topology of the OmpC, OmpF, and PhoE porins.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.